Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
February 27 2024 - 5:10PM
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial
results for the quarter ended December 31, 2023 before the market
opens on March 7, 2024, and will hold a conference call to discuss
the results at 8:00 a.m. Eastern Time.
Participants who would like to join the call and
ask a question must register here. Once registered, you will
receive the dial-in numbers and a unique PIN number.
Participants who would like to join the
audio-only webcast should go to our events and presentations on the
investor website here.
Financial information presented on the call,
including the earnings release and a related slide presentation,
will be available on the Investor Relations section of Harvard
Bioscience’s website.
About Harvard
Bioscience
Harvard Bioscience, Inc. is a leading developer,
manufacturer and seller of technologies, products and services that
enable fundamental advances in life science applications, including
research, pharmaceutical and therapy discovery, bio-production and
preclinical testing for pharmaceutical and therapy development. Our
customers range from renowned academic institutions and government
laboratories to the world’s leading pharmaceutical, biotechnology
and contract research organizations. With operations in the United
States, Europe, and China, we sell through a combination of direct
and distribution channels to customers around the world.For more
information, please visit our website
at www.harvardbioscience.com.
Investor Inquiries:Harvard
Bioscience, Inc.Investor Relationsinvestors@harvardbioscience.com
(508) 893-3120
Harvard Bioscience (NASDAQ:HBIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Harvard Bioscience (NASDAQ:HBIO)
Historical Stock Chart
From Apr 2023 to Apr 2024